MedPath
HSA Approval

ATRACURIUM LABATEC IV SOLUTION FOR INJECTION 10MG/ML

SIN14836P

ATRACURIUM LABATEC IV SOLUTION FOR INJECTION 10MG/ML

ATRACURIUM LABATEC IV SOLUTION FOR INJECTION 10MG/ML

August 28, 2015

ALLIANCE PHARM PTE. LTD.

ALLIANCE PHARM PTE. LTD.

Regulatory Information

HSA regulatory responsibility and product classification details

Regulatory Responsibility

RegistrantALLIANCE PHARM PTE. LTD.
Licence HolderALLIANCE PHARM PTE. LTD.

Product Classification

D
Drug Type
Therapeutic
F
Forensic Class
Prescription Only
HSA Singapore Classification

Formulation Information

INJECTION, SOLUTION

INTRAVENOUS

Medical Information

M03AC04

atracurium

Manufacturer Information

ALLIANCE PHARM PTE. LTD.

Hikma Farmacêutica (Portugal), S.A

Active Ingredients

Atracurium Besylate

10 mg/ml

Atracurium besylate

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

ATRACURIUM LABATEC IV SOLUTION FOR INJECTION 10MG/ML - HSA Approval | MedPath